
Journal of Medicinal Chemistry p. 342 - 346 (1986)
Update date:2022-08-03
Topics:
Cross, Peter E.
Dickinson, Roger P.
Parry, M. John
Randall, Michael J.
The preparation of a series of 3-(1H-imidazol-1-ylmethyl)-1H-indole-1-alkanoic acids is described.Several compounds were found to be more potent thromboxane synthetase inhibitors than the corresponding analogues lacking an acidic substituent.In the cases examined, compounds had no significant activity against PGI2 synthetase or cyclooxygenase, and introduction of the carboxylic acid substituent led to a reduction in activity against adrenal steroid 11β-hydroxylase.Compound 21 strongly inhibited thromboxane formation after iv administration to anesthetized rabbitsand oral administration to conscious dogs.The compound had a long duration of action, and marked inhibition of thromboxane production was observed 15 h after oral administration of 1 mg/kg to conscious dogs.
View MoreContact:+86-579-85206992
Address:No 451 chouzhou north road ,room 1106 int'l business center , yiwu ,china
Nanjing distinctions Medical Technology Co., Ltd.(expird)
Contact:+86-15996203785 13914714059
Address:nanjing,jiangsu , China
Chongqing KonAo Health Co.,Ltd
Contact:13687578375
Address:wuhan hubei china
Wuhan Chemwish Technology Co., Ltd
website:http://www.chemwish.com/
Contact:+86-27-67849912
Address:Room 1311, Unit 2, Block1, Innovation Road East Lake High-tech Development Zone Wuhan, Hubei,P.R. China
website:http://www.ringchemicals.com/
Contact:+1-416-493-6870
Address:Toronto, Canada
Doi:10.1016/S0960-894X(00)00201-8
(2000)Doi:10.1016/j.bmcl.2017.11.028
(2018)Doi:10.1021/ja035988m
(2003)Doi:10.1021/jo01031a022
(1964)Doi:10.1016/0040-4039(80)80212-7
(1980)Doi:10.1016/0040-6031(82)87133-5
(1982)